Completed NA INTERVENTIONAL 2-arm NCT04211688

Effectiveness of a Combined Group-individual Schema Therapy for Borderline Personality Disorder

Real-world Effectiveness of a Combined Group-individual Schema Therapy for Borderline Personality Disorder: A Pragmatic Randomized Clinical Trial

Sponsor: Consorci Sanitari del Maresme

Conditions Borderline Personality Disorder Randomized Controlled Trial

Interventions Group Schema therapy Individual Schema therapy

Updated 4 times since 2020 Last updated: Dec 23, 2019 Started: Jan 12, 2017 Primary completion: Dec 1, 2019 Completion: Dec 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Borderline Personality Disorder and Randomized Controlled Trial and is currently completed. Consorci Sanitari del Maresme leads this study, which shows 4 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Consorci Sanitari del Maresme
Department of Health, Generalitat de Catalunya

Data source: Consorci Sanitari del Maresme

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.